Esther M. Heuts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Esther M. Heuts has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Piatkowski
Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre+, P.O. box 5800, 6202 AZ Maastricht, the Netherlands; NUTRIM School for Nutrition, and Translational Research in Metabolism, Maastricht University, P.O. Box 616, Universiteitssingel 40, 6229 ER Maastricht, the Netherlands
7 shared publications - René Remmelt Willie Johan van der Hulst
Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre +, Maastricht, Netherlands
6 shared publications - Adri C. Voogd
Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
5 shared publications - Marc B. I. Lobbes
Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, the Netherlands
4 shared publications - Marjolein L. Smidt
Department of Surgery, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
4 shared publications - Jop Beugels
Department of Plastic Surgery, Maastricht University Medical Center +, Maastricht, The Netherlands
3 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 123, 370-378
Use of preoperative computed tomography angiography and magnetic resonance angiography for deep inferior epigastric perforator flap breast reconstruction: A 15-year multicenter retrospective analysis
- 9 October 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 123, 370-378
Open AccessUse of preoperative computed tomography angiography and magnetic resonance angiography for deep inferior epigastric perforator flap breast reconstruction: A 15-year multicenter retrospective analysis
- Open Access
- 24 August 2026
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 13
Treatment and survival of de novo HER2-positive metastatic breast cancer across regional cancer networks in the Netherlands: a cohort study
- 24 August 2026
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 13
Open AccessTreatment and survival of de novo HER2-positive metastatic breast cancer across regional cancer networks in the Netherlands: a cohort study
- Open Access
- 27 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 346-360
Autologous fat transfer for complete breast reconstruction in irradiated breast cancer patients: A systematic review
- 27 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 346-360
Open AccessAutologous fat transfer for complete breast reconstruction in irradiated breast cancer patients: A systematic review
- Open Access
- 22 November 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 193-204
Patient satisfaction after breast reconstruction in a high-risk breast cancer population
- 22 November 2025
- Published by Elsevier in JPRAS Open
- Vol. 48, 193-204
Open AccessPatient satisfaction after breast reconstruction in a high-risk breast cancer population
- Open Access
- 30 January 2025
- Published by Elsevier in JPRAS Open
- Vol. 44, 1-10
Prevalence of Silicone Lymphadenopathy in Women with Breast Implants: A single-center retrospective study
- 30 January 2025
- Published by Elsevier in JPRAS Open
- Vol. 44, 1-10
Open AccessPrevalence of Silicone Lymphadenopathy in Women with Breast Implants: A single-center retrospective study
- Open Access
- 23 August 2024
- Published by Elsevier in JPRAS Open
- Vol. 42, 113-132
Radiologic findings in women after Autologous Fat Transfer (AFT) based breast reconstruction: A Systematic Review
- 23 August 2024
- Published by Elsevier in JPRAS Open
- Vol. 42, 113-132
Open AccessRadiologic findings in women after Autologous Fat Transfer (AFT) based breast reconstruction: A Systematic Review
- Open Access
- 1 October 2021
- Published by Elsevier in The Breast
- Vol. 59, 176-182
Breast-related and body-related quality of life following autologous breast reconstruction is superior to implant-based breast reconstruction - A long-term follow-up study
- 1 October 2021
- Published by Elsevier in The Breast
- Vol. 59, 176-182
Open AccessBreast-related and body-related quality of life following autologous breast reconstruction is superior to implant-based breast reconstruction - A long-term follow-up study
- Open Access
- 24 May 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 188 (2) , 389-398
The difference in local, regional and distant breast cancer recurrence between the immediate and delayed DIEP flap procedure; a retrospective cohort study
Purpose: It has been hypothesized that autologous breast reconstruction can cause reactivation of dormant micro metastases by its extensive tissue trauma, influencing the risk of breast cancer recurrence. However, about the specific effect of timing on breast cancer recurrence in the deep inferior epigastric perforator (DIEP) flap reconstruction is not much known. In this study the rate of local, regional and distant recurrence between patients undergoing an immediate and delayed autologous DIEP flap breast reconstruction were evaluated. Methods: In this retrospective cohort study, breast cancer patients undergoing a DIEP flap breast reconstruction between 2010 and 2018 in three hospitals in the Netherlands were evaluated. Cox proportional hazards regression analyses were performed to assess the impact of different factors on breast cancer recurrence. The primary endpoint was local breast cancer recurrence. Secondary endpoints were regional and distant recurrence. Results: A total of 919 DIEP-flap reconstructions were done in 862 women of which 347 were immediate- and 572 were delayed DIEP flap reconstructions. After a median follow-up of 46 months and 86 months respectively (p < 0.001), local breast cancer recurrence occurred in 1.5% and in 1.7% of the patients resulting in an adjusted hazard ratio of 2.890 (p = 0.001, 95% CI 1.536, 5437). Conclusion: This study suggests an increased risk for breast cancer recurrence in women receiving a delayed DIEP flap reconstruction as compared to women receiving an immediate DIEP flap reconstruction. However, these data should be interpreted carefully as a result of selection bias.
- 24 May 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 188 (2) , 389-398
Open AccessThe difference in local, regional and distant breast cancer recurrence between the immediate and delayed DIEP flap procedure; a retrospective cohort study
Purpose: It has been hypothesized that autologous breast reconstruction can cause reactivation of dormant micro metastases by its extensive tissue trauma, influencing the risk of breast cancer recurrence. However, about the specific effect of timing on breast cancer recurrence in the deep inferior epigastric perforator (DIEP) flap reconstruction is not much known. In this study the rate of local, regional and distant recurrence between patients undergoing an immediate and delayed autologous DIEP flap breast reconstruction were evaluated. Methods: In this retrospective cohort study, breast cancer patients undergoing a DIEP flap breast reconstruction between 2010 and 2018 in three hospitals in the Netherlands were evaluated. Cox proportional hazards regression analyses were performed to assess the impact of different factors on breast cancer recurrence. The primary endpoint was local breast cancer recurrence. Secondary endpoints were regional and distant recurrence. Results: A total of 919 DIEP-flap reconstructions were done in 862 women of which 347 were immediate- and 572 were delayed DIEP flap reconstructions. After a median follow-up of 46 months and 86 months respectively (p < 0.001), local breast cancer recurrence occurred in 1.5% and in 1.7% of the patients resulting in an adjusted hazard ratio of 2.890 (p = 0.001, 95% CI 1.536, 5437). Conclusion: This study suggests an increased risk for breast cancer recurrence in women receiving a delayed DIEP flap reconstruction as compared to women receiving an immediate DIEP flap reconstruction. However, these data should be interpreted carefully as a result of selection bias.
- Open Access
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
This retrospective study investigated the value of pretreatment contrast-enhanced Magnetic Resonance Imaging (MRI)-based radiomics for the prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients. A total of 292 breast cancer patients, with 320 tumors, who were treated with neo-adjuvant systemic therapy and underwent a pretreatment MRI exam were enrolled. As the data were collected in two different hospitals with five different MRI scanners and varying acquisition protocols, three different strategies to split training and validation datasets were used. Radiomics, clinical, and combined models were developed using random forest classifiers in each strategy. The analysis of radiomics features had no added value in predicting pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients compared with the clinical models, nor did the combined models perform significantly better than the clinical models. Further, the radiomics features selected for the models and their performance differed with and within the different strategies. Due to previous and current work, we tentatively attribute the lack of improvement in clinical models following the addition of radiomics to the effects of variations in acquisition and reconstruction parameters. The lack of reproducibility data (i.e., test-retest or similar) meant that this effect could not be analyzed. These results indicate the need for reproducibility studies to preselect reproducible features in order to properly assess the potential of radiomics.
Open AccessMRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
This retrospective study investigated the value of pretreatment contrast-enhanced Magnetic Resonance Imaging (MRI)-based radiomics for the prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients. A total of 292 breast cancer patients, with 320 tumors, who were treated with neo-adjuvant systemic therapy and underwent a pretreatment MRI exam were enrolled. As the data were collected in two different hospitals with five different MRI scanners and varying acquisition protocols, three different strategies to split training and validation datasets were used. Radiomics, clinical, and combined models were developed using random forest classifiers in each strategy. The analysis of radiomics features had no added value in predicting pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients compared with the clinical models, nor did the combined models perform significantly better than the clinical models. Further, the radiomics features selected for the models and their performance differed with and within the different strategies. Due to previous and current work, we tentatively attribute the lack of improvement in clinical models following the addition of radiomics to the effects of variations in acquisition and reconstruction parameters. The lack of reproducibility data (i.e., test-retest or similar) meant that this effect could not be analyzed. These results indicate the need for reproducibility studies to preselect reproducible features in order to properly assess the potential of radiomics.